BioScrip Reports Second Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Tech stocks weigh on Wall Street as Iran stalemate lifts oil, yields
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Wall Street indexes slip as oil prices rise, retail results awaited
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Trump threatens to bomb Oman over Iran stance
- U.S. EV market shows signs of bottoming out: Bernstein
BioScrip (BIOS) PT Raised to $4 at Jefferies; Reiterates Buy
August 9, 2017 8:35 AM EDTJefferies raised its price target on BioScrip (NASDAQ: BIOS) to $4.00 (from $3.00) while maintaining a Buy rating following 2Q. EBITDA of $10MM was ahead of consensus and nearly doubled on a sequential basis, while Core revenue was up 2% Q/Q and grew to 73.1% of total... More
BioScrip (BIOS) Misses Q2 EPS by 14c, Revs Modestly Lower; Reiterates Outlook
August 8, 2017 8:03 AM EDTBioScrip (NASDAQ: BIOS) reported Q2 EPS of ($0.26), $0.14 worse than the analyst estimate of ($0.12). Revenue for the quarter came in at $218.1 million versus the consensus estimate of $220.17 million.
2017 Guidance
The Company is reiterating its prior guidance of adjusted EBITDA in the range of... More
